J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 2791-2801; DOI 10.1099/vir.0.82164-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, E.
Right arrow Articles by Lobigs, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, E.
Right arrow Articles by Lobigs, M.
Agricola
Right arrow Articles by Lee, E.
Right arrow Articles by Lobigs, M.
© 2006 Society for General Microbiology

Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination

Eva Lee1, Peter J. Wright2, Andrew Davidson3 and Mario Lobigs1

1 John Curtin School of Medical Research, Division of Immunology and Genetics, Australian National University, PO Box 334, Canberra, ACT 2600, Australia
2 Department of Microbiology, Monash University, Clayton, VIC, Australia
3 Department of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK

Correspondence
Eva Lee
Eva.Lee{at}anu.edu.au

To gain insight into the role of cell surface glycosaminoglycans (GAG) in dengue virus (DEN) cell tropism and virulence, DEN-2 mouse brain-adapted vaccine candidate, neurovirulent prototype strain (NGC) and low-passage strain, PUO-218, were passaged in BHK-21 and SW13 cells to isolate variants with high affinity for GAG. Sequence comparisons of parent and passage variants revealed five GAG-binding determinants, which all cluster in a surface-exposed region in domain II of the three-dimensional structure of the DEN envelope protein. Using an infectious cDNA clone of NGC and an NGC/PUO-218 prM–E chimeric clone, it was demonstrated that the GAG-binding determinants augment the specific infectivity for BHK-21 and/or SW13 cells by 10- to 170-fold and in some cases marginally reduce that for Vero cells. This altered cell tropism was due to a greater dependence of the variants on cell surface GAG for attachment/entry, given their increased susceptibility to heparin inhibition. The effect of the GAG-binding determinants on virulence was examined in mice deficient in alpha/beta/gamma interferon responses. High GAG affinity strongly correlated with low neuroinvasiveness due to rapid virus clearance from the blood. It was speculated that this mechanism accounts for the attenuation in primates of some DEN vaccine candidates. Interestingly, the GAG-binding variants did not display marked attenuation of neurovirulence and the opposing effect of enhanced neurovirulence was associated with one determinant (Lys126) already present in mouse brain-adapted NGC. This discrepancy of attenuated neuroinvasiveness and augmented neurovirulence may be reconciled by the existence of different mechanisms of virus dissemination in the brain and in extraneural tissues.

Published online ahead of print on 20 June 2006 as DOI 10.1099/vir.0.82164-0.




This article has been cited by other articles:


Home page
J. Virol.Home page
G. Anez, R. Men, K. H. Eckels, and C.-J. Lai
Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques
J. Virol., October 15, 2009; 83(20): 10384 - 10394.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Suzuki, E. R. Winkelmann, and P. W. Mason
Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
J. Virol., February 15, 2009; 83(4): 1870 - 1880.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Nickells, M. Cannella, D. A. Droll, Y. Liang, W. S. M. Wold, and T. J. Chambers
Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model
J. Virol., December 15, 2008; 82(24): 12510 - 12519.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. R. Prestwood, D. M. Prigozhin, K. L. Sharar, R. M. Zellweger, and S. Shresta
A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads
J. Virol., September 1, 2008; 82(17): 8411 - 8421.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Lee and M. Lobigs
E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence
J. Virol., June 15, 2008; 82(12): 6024 - 6033.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 by the Society for General Microbiology.